EU updates EudraLex Q&A on requirements for drug/device trials
This article was originally published in SRA
Executive Summary
The European Commission has issued an updated question & answer document on its guidance for pharmaceutical clinical trials (EudraLex Volume 10), explaining the implications of the current EU clinical trials legislation if the study also involves a medical device1,2.